Our results showed that p-Akt was upregulated due to DCAF1 overexpression, and the Akt inhibitor partially abrogated DCAF1-mediated cell proliferation and invasion, indicating that DCAF1 promotes HCC progression by activating the Akt signaling pathway. Here, AKT1 is linked to hepatocellular carcinoma.